In terms of studies on human cancer tissue, PTEN gene mutations are more frequently detected in SCC than in adenocarcinoma, e.g., 19% of lung [21], 15% of head and neck [22], 11% of oesophageal [23], and 6%–11% of other cancers [15, 24]. This evidence concerns the gene PTEN and adenocarcinoma.